Immunomic Therapeutics Company
Immunomic Therapeutics is a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms.
Investors
Headquarters:
Lancaster, Pennsylvania, United States
Funding Status:
Private
Industry:
Immuno-Virotherapies
Founded Date:
2005